News

MyChesCo on MSN1d
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, ...
Multiple Sclerosis News Today1d
Aetna agrees to reimburse PoNS device for MS patients
Helius Medical Technologies calls the out-of-network reimbursement the first step in making the PoNS device more accessible to MS patients.
MyChesCo on MSN2d
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement
Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for ...
Helius Medical Technologies, Inc.: Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy® on gait deficit improvement in people with Multiple Sclerosis- -Presentation of ...
The Manila Times2d
Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting
CMSC attendees were encouraged at Helius' recent successes in obtaining initial reimbursement from federal and private payers ...
Small-Cap Disruptors KZIA, SNYR, HSDT, TRNR, PRSO Lead Momentum More Microcap Stocks Inside
A new wave of innovation is reshaping small-cap markets across sectors including oncology, functional energy beverages, ...
Helius Medical Stock Is Soaring Wednesday: What's Going On?
Helius Medical Technologies (NASDAQ:HSDT) shares are trading higher Wednesday after the company announced an authorized claim ...
SciELO6d
Pedro Pons’ sign of brucellar spondylitis
Computed tomography scan showing apparent destruction at the anterior superior corner of the L4 vertebra (Pedro Pons’ sign) accompanied by prominent osteosclerosis and osteophytes resembling a ...